Business Trends– category –
-
Business Trends
Jazz Pharmaceuticals and AbCellera Partner for Next-Gen Multispecific T-Cell Engagers Targeting GI and Solid Tumors, with Up to $848M in Potential Payments
PR Newswire USA Overview Jazz Pharmaceuticals and AbCellera have entered a research collaboration, option, and license agreement to discover and develop next-generation multispecific T-cell engager antibodies for gastrointestinal cancers... -
Business Trends
Autolus Therapeutics Wins Prix Galien UK for Best Biotech Product, Reports Promising Early Phase 1 Data for obe-cel CAR-T in Refractory SLE
Stock Titan UK Overview Autolus Therapeutics plc received the 2026 Prix Galien UK Award for Best Biotechnology Product, recognizing its pioneering work in next-generation T-cell therapies developed with University College London. Concurr... -
Business Trends
Editas Medicine Unveils Positive Preclinical Data for Gene Editing Candidate EDIT-401, Demonstrating Significant Reduction in LDL, Lp(a), and ApoB in Non-Human Primates
Investing.com USA Overview Editas Medicine announced positive preclinical data for its gene editing therapeutic candidate EDIT-401, showing significant reductions in LDL cholesterol, lipoprotein(a) (Lp(a)), and apolipoprotein B (ApoB) in... -
Business Trends
Intellia’s Lonvo-z Achieves 87% Reduction in HAE Attack Rate and 62% Attack-Free Patients in Pivotal Phase 3 In Vivo CRISPR Trial
GlobeNewswire USA Overview Intellia Therapeutics has reported highly positive Phase 3 HAELO clinical trial results for lonvoguran ziclumeran (lonvo-z), an in vivo CRISPR gene editing therapy for hereditary angioedema (HAE). The therapy a... -
Business Trends
Neion Bio Secures $23M Series A to Advance Chicken Egg-Based Biologics API Manufacturing
Endpoints News USA Overview Neion Bio successfully raised $23 million in Series A funding to further develop its innovative technology for producing active pharmaceutical ingredients (APIs) for biologics from chicken eggs. This funding w... -
Business Trends
Kuraray Reaffirms Plans for New U.S. Liquid Rubber Facility to Bolster Global TPE Supply and Sustainable Products
European Rubber Journal Japan Overview Kuraray has reconfirmed its strategic plan to construct a new liquid rubber manufacturing facility in the United States. This investment is integral to the company's isoprene business segment develo... -
Business Trends
ARLANXEO and Covestro Bolster Sustainable Rubber Production Using ISCC PLUS Certified Materials, Advancing Climate Neutrality Goals
MarketScreener Germany Overview ARLANXEO and Covestro are intensifying their collaboration to promote sustainable rubber production by utilizing ISCC PLUS certified mass-balanced raw materials. This partnership aims to reduce reliance on... -
Business Trends
Evonik Initiates Pilot Production of AEM Electrolysis Membranes in Marl, Germany, Targeting 2.5 GW Capacity Annually
Renewables Now Germany Overview Evonik Industries AG has commenced pilot production of high-performance membranes for Anion Exchange Membrane (AEM) electrolysis at its facility in Marl, Germany. The new plant is capable of producing memb... -
Business Trends
Uluu Secures $16M for Marine Degradable PHA Materials, Mitsubishi Chemical and PopSockets Partner on Plant-Derived DURABIO
openPR.com USA Overview Uluu successfully raised $16 million in Series A funding to accelerate the commercialization of marine degradable polyhydroxyalkanoate (PHA) materials. Concurrently, Mitsubishi Chemical Group partnered with PopSoc... -
Business Trends
IBM Invests Over $10 Billion in Quantum Computing: Targeting Fault-Tolerant ‘Quantum Starling’ by 2029 and Building First U.S. Quantum Foundry ‘Anderon’
Futurum Research USA Overview IBM has announced a plan to invest over $10 billion in quantum computing over the next five years, aiming to develop the large-scale, fault-tolerant 'IBM Quantum Starling' by 2029. This investment covers R&a...